Apalutamide
Janssen
['apa ']
startar: ph 2 salvage trial of adt + apa + rt f/b doce in psa recurrent pca after rp n=39 pfs rate: @ 24 mos 84%; @ 36 mos 72% 95% t recovery @ 36 mos any-gr aes: 98% hot flashes, 88% fatigue, 77% alopecia, 57% dysgeusia, 53% rash #asco23 
Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor